Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the European Society of Gene & Cell Therapy has accepted six Sangamo abstracts for presentation at the 30th Annual...
Source: marketscreener.com